{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:59:50Z","timestamp":1788368390021,"version":"build-2803163510"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,18]],"date-time":"2022-12-18T00:00:00Z","timestamp":1671321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ajpc.2022.100451","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T02:24:41Z","timestamp":1671416681000},"page":"100451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Imaging subclinical coronary atherosclerosis to guide lipid management, are we there yet?"],"prefix":"10.1016","volume":"13","author":[{"given":"Pamela","family":"Pi\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lorenzatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Daich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo L","family":"Schenone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gongora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario J","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3091-3735","authenticated-orcid":false,"given":"Leandro","family":"Slipczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.ajpc.2022.100451_bib0001","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ajpc.2022.100451_bib0002","first-page":"e596","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003670","article-title":"Use and customization of risk scores for predicting cardiovascular events using electronic health record data","volume":"6","author":"Wolfson","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"10.1016\/j.ajpc.2022.100451_bib0004","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacc.2015.10.058","article-title":"Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment","volume":"67","author":"Yeboah","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0006","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCOUTCOMES.113.000799","article-title":"Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis","volume":"7","author":"Pletcher","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"15","key":"10.1016\/j.ajpc.2022.100451_bib0007","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2011.01.019","article-title":"Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial","volume":"57","author":"Rozanski","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ajpc.2022.100451_bib0008","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/ehjci\/jeaa168","article-title":"Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial","volume":"21","author":"van der Aalst","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0009","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/01.ATV.0000112023.62695.7f","article-title":"Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo","volume":"24","author":"Tintut","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"22","key":"10.1016\/j.ajpc.2022.100451_bib0010","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting","volume":"135","author":"Natarajan","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0011","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcct.2019.05.014","article-title":"Exploring the intersection between genetic risk scores and coronary artery calcium- mutually exclusive or complementary?","volume":"14","author":"Cainzos-Achirica","year":"2020","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"10","key":"10.1016\/j.ajpc.2022.100451_bib0012","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jamacardio.2021.2321","article-title":"Assessment of coronary artery calcium scoring to guide statin therapy allocation according to risk-enhancing factors: the multi-ethnic study of atherosclerosis","volume":"6","author":"Patel","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2022.100451_bib0013","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.numecd.2022.05.006","article-title":"Dyslipidemia and coronary artery calcium: from association to development of a risk-prediction nomogram","volume":"32","author":"Wang","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.ajpc.2022.100451_bib0014","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.CIR.49.6.1247","article-title":"The significance of coronary calcification detected by fluoroscopy. A report of 360 patients","volume":"49","author":"Bartel","year":"1974","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0015","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1148\/radiology.137.3.7444045","article-title":"The diagnostic and prognostic significance of coronary artery calcification. A report of 800 cases","volume":"137","author":"Margolis","year":"1980","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0016","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ajpc.2022.100451_bib0017","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2214\/AJR.04.0333","article-title":"Concordance of coronary artery calcium estimates between MDCT and electron beam tomography","volume":"185","author":"Daniell","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0018","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary calcium score and cardiovascular risk","volume":"72","author":"Greenland","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajpc.2022.100451_bib0019","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jcmg.2017.05.007","article-title":"Coronary artery calcium scoring: is it time for a change in methodology?","volume":"10","author":"Blaha","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcct.2018.03.008","article-title":"CAC-DRS: coronary artery calcium data and reporting system. An expert consensus document of the society of cardiovascular computed tomography (SCCT)","volume":"12","author":"Hecht","year":"2018","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0021","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/jama.2013.282535","article-title":"Calcium density of coronary artery plaque and risk of incident cardiovascular events","volume":"311","author":"Criqui","year":"2014","journal-title":"JAMA J Am Med Assoc"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jcct.2010.11.002","article-title":"Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD Gene cohort","volume":"5","author":"Budoff","year":"2011","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0023","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcct.2017.02.010","article-title":"Clinical indications for coronary artery calcium scoring in asymptomatic patients: expert consensus statement from the Society of cardiovascular computed tomography","volume":"11","author":"Hecht","year":"2017","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0024","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcct.2016.11.003","article-title":"SCCT\/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: a report of the society of cardiovascular computed tomography and society of thoracic radiology","volume":"11","author":"Hecht","year":"2017","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"6","key":"10.1016\/j.ajpc.2022.100451_bib0025","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcmg.2009.03.009","article-title":"Absence of coronary artery calcification and all-cause mortality","volume":"2","author":"Blaha","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ajpc.2022.100451_bib0026","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jcmg.2008.12.031","article-title":"Diagnostic and prognostic value of absence of coronary artery calcification","volume":"2","author":"Sarwar","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.ajpc.2022.100451_bib0027","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.115.018524","article-title":"Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the multi-ethnic study of atherosclerosis (MESA)","volume":"133","author":"Blaha","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2010.02.021","article-title":"High-risk plaque initiative. The BioImage study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease\u2013study design and objectives","volume":"160","author":"Muntendam","year":"2010","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ajpc.2022.100451_bib0127","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jacc.2005.05.049","article-title":"Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project","volume":"46","author":"Taylor","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0128","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCULATIONAHA.104.488916","article-title":"Coronary calcification improves cardiovascular risk prediction in the elderly","volume":"112","author":"Vliegenthart","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajpc.2022.100451_bib0129","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/aje\/kwi228","article-title":"Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women","volume":"162","author":"LaMonte","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jacc.2005.02.088","article-title":"Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events","volume":"46","author":"Arad","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ajpc.2022.100451_bib0131","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.jacc.2006.10.079","article-title":"Long-term prognosis associated with coronary calcification","volume":"49","author":"Budoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2022.100451_bib0132","first-page":"10","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","author":"Detrano","year":"2008","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ajpc.2022.100451_bib0133","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacc.2010.06.030","article-title":"Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study","volume":"56","author":"Erbel","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0134","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamacardio.2016.5493","article-title":"Association of coronary artery calcium in adults aged 32 to 46 years with incident coronary heart disease and death","volume":"2","author":"Carr","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2022.100451_bib0135","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jcmg.2019.08.024","article-title":"Interplay of coronary artery calcium and risk factors for predicting CVD\/CHD mortality: the CAC consortium","volume":"13","author":"Grandhi","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"25","key":"10.1016\/j.ajpc.2022.100451_bib0101","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1016\/j.jacc.2018.09.051","article-title":"Impact of statins on cardiovascular outcomes following coronary artery calcium scoring","volume":"72","author":"Mitchell","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0136","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jcmg.2019.11.009","article-title":"Association of statin use with cardiovascular outcomes by coronary calcium: MESA","volume":"13","author":"Zhou","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"15","key":"10.1016\/j.ajpc.2022.100451_bib0029","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.jacc.2015.07.066","article-title":"Implications of coronary artery calcium testing among statin candidates according to American college of cardiology\/American heart association cholesterol management guidelines: MESA (Multi-ethnic study of atherosclerosis)","volume":"66","author":"Nasir","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jcct.2019.03.012","article-title":"Coronary artery calcium scoring in low risk patients with family history of coronary heart disease: validation of the SCCT guideline approach in the coronary artery calcium consortium","volume":"13","author":"Dudum","year":"2019","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"1_Part_1","key":"10.1016\/j.ajpc.2022.100451_bib0031","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcmg.2019.02.005","article-title":"Long-term all-cause and cause-specific mortality in asymptomatic patients with CAC \u22651000","volume":"13","author":"Peng","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ajpc.2022.100451_bib0032","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2022.02.006","article-title":"Coronary artery calcium scores indicating secondary prevention level risk: findings from the CAC consortium and FOURIER trial","volume":"347","author":"Dzaye","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100451_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025737","article-title":"Coronary artery calcium score to refine the use of PCSK9i in asymptomatic individuals: a multicohort study","author":"Cainzos-Achirica","year":"2022","journal-title":"J Am Heart Assoc."},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0034","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcmg.2021.10.017","article-title":"CAC for risk stratification among individuals with hypertriglyceridemia free of clinical atherosclerotic cardiovascular disease","volume":"15","author":"Cainzos-Achirica","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.ajpc.2022.100451_bib0035","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamacardio.2017.4191","article-title":"Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis","volume":"2","author":"Malik","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2022.100451_bib0036","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2337\/dc20-0166","article-title":"Sex differences in coronary artery calcium and mortality from coronary heart disease, cardiovascular disease, and all causes in adults with diabetes: the coronary calcium consortium","volume":"43","author":"Wong","year":"2020","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0037","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003528","article-title":"Absence of coronary artery calcium identifies asymptomatic diabetic individuals at low near-term but not long-term risk of mortality: a 15-year follow-up study of 9715 patients","volume":"9","author":"Valenti","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0038","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcmg.2015.11.011","article-title":"Noninvasive cardiovascular risk assessment of the asymptomatic diabetic patient: the imaging council of the American college of cardiology","volume":"9","author":"Budoff","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ajpc.2022.100451_bib0039","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2019.09.014","article-title":"Clinical significance of zero coronary artery calcium in individuals with LDL cholesterol \u2265190\u00a0mg\/dL: the multi-ethnic study of atherosclerosis","volume":"292","author":"Sandesara","year":"2020","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ajpc.2022.100451_bib0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014135","article-title":"Visual coronary and aortic calcium scoring on chest computed tomography predict mortality in patients with low-density lipoprotein-cholesterol \u2265190 mg\/dL","volume":"15","author":"Castagna","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"issue":"19","key":"10.1016\/j.ajpc.2022.100451_bib0041","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.jacc.2022.02.051","article-title":"Distribution of coronary artery calcium by age, sex, and race among patients 30-45 years old","volume":"79","author":"Javaid","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0042","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jacc.2021.05.011","article-title":"Progression of Early Subclinical Atherosclerosis (PESA) study: JACC focus seminar 7\/8","volume":"78","author":"Ibanez","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2022.100451_bib0043","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jcmg.2020.06.048","article-title":"Warranty period of a calcium score of zero: comprehensive analysis from MESA","volume":"14","author":"Dzaye","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.ajpc.2022.100451_bib0044","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jcmg.2010.08.018","article-title":"Progression of coronary artery calcium predicts all-cause mortality","volume":"3","author":"Budoff","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.ajpc.2022.100451_bib0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/CIRCULATIONAHA.116.027034","article-title":"Value of progression of coronary artery calcification for risk prediction of coronary and cardiovascular events: result of the HNR study (Heinz Nixdorf Recall)","volume":"137","author":"Lehmann","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ajpc.2022.100451_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.7440","article-title":"Association of coronary artery calcium with long-term, cause-specific mortality among young adults","volume":"2","author":"Miedema","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajpc.2022.100451_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2022.03.010","article-title":"Coronary atherosclerosis in an asymptomatic U.S. population","author":"Nasir","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"0","key":"10.1016\/j.ajpc.2022.100451_bib0048","article-title":"Plaque burden and 1-year outcomes in acute chest pain","volume":"0","author":"Meah","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0049","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcct.2021.10.004","article-title":"Detection of small coronary calcifications in patients with Agatston coronary artery calcium score of zero","volume":"16","author":"Tzolos","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"24","key":"10.1016\/j.ajpc.2022.100451_bib0050","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.116.024360","article-title":"Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)","volume":"135","author":"Hoffmann","year":"2017","journal-title":"Circulation"},{"issue":"9985","key":"10.1016\/j.ajpc.2022.100451_bib0051","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(15)60291-4","article-title":"SCOT-HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial","volume":"385","year":"2015","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0052","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamacardio.2021.4406","article-title":"Association of age with the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients","volume":"7","author":"Mortensen","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2022.100451_bib0053","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcct.2014.07.003","article-title":"SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee","volume":"8","author":"Leipsic","year":"2014","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0137","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.081380","volume":"126","author":"Cho","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0138","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.atherosclerosis.2013.09.025","article-title":"Incremental prognostic value of coronary computed tomographic angiography over coronary artery calcium score for risk prediction of major adverse cardiac events in asymptomatic diabetic individuals","volume":"232","author":"Min","year":"2014","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.ajpc.2022.100451_bib0139","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jcmg.2016.01.040","article-title":"Long-term prognostic value of coronary CT angiography in asymptomatic type 2 DIABETES Mellitus","volume":"9","author":"Kang","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7 Pt 2","key":"10.1016\/j.ajpc.2022.100451_bib0140","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcmg.2018.02.025","article-title":"Plaque morphology as predictor of late plaque events in patients with asymptomatic type 2 diabetes: a long-term observational study","volume":"12","author":"Halon","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0141","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/ATVBAHA.114.304351","article-title":"Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease","volume":"35","author":"Chow","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.ajpc.2022.100451_bib0142","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.jcmg.2021.05.022","article-title":"Reduction of myocardial infarction and all-cause mortality associated to statins in patients without obstructive CAD","volume":"14","author":"\u00d8vrehus","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"24","key":"10.1016\/j.ajpc.2022.100451_bib0054","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.jacc.2020.10.021","article-title":"Impact of plaque burden versus stenosis on ischemic events in patients with coronary atherosclerosis","volume":"76","author":"Mortensen","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcct.2021.07.001","article-title":"Quantitative assessment of atherosclerotic plaque, recent progress and current limitations","volume":"16","author":"Williams","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0056","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCIMAGING.113.001047","article-title":"Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events","volume":"7","author":"Bittencourt","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10.1016\/j.ajpc.2022.100451_bib0057","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.121.055340","article-title":"Prevalence of subclinical coronary artery atherosclerosis in the general population","volume":"144","author":"Bergstr\u00f6m","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ajpc.2022.100451_bib0058","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1007\/s00330-021-08481-w","article-title":"Additive value of epicardial adipose tissue quantification to coronary CT angiography\u2013derived plaque characterization and CT fractional flow reserve for the prediction of lesion-specific ischemia","volume":"32","author":"Brandt","year":"2022","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.ajpc.2022.100451_bib0059","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jcmg.2022.02.004","article-title":"Pericoronary adipose tissue attenuation, low-attenuation plaque burden, and 5-year risk of myocardial infarction","volume":"15","author":"Tzolos","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcct.2016.04.005","volume":"10","author":"Cury","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"5","key":"10.1016\/j.ajpc.2022.100451_bib0061","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/pcad.2002.122475","article-title":"Pathology of the unstable plaque","volume":"44","author":"Virmani","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0062","first-page":"363","article-title":"Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging","volume":"71","author":"Motoyama","year":"2007","journal-title":"Circ J Off J Jpn Circ Soc"},{"issue":"7","key":"10.1016\/j.ajpc.2022.100451_bib0063","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacc.2014.05.039","article-title":"High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial","volume":"64","author":"Puchner","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0064","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0735-1097(01)01374-2","article-title":"Arterial remodeling and coronary artery disease: the concept of \u201cdilated\u201d versus \u201cobstructive\u201d coronary atherosclerosis","volume":"38","author":"Schoenhagen","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcct.2020.11.002","article-title":"Society of cardiovascular computed tomography \/North American society of cardiovascular imaging - expert consensus document on coronary ct imaging of atherosclerotic plaque","volume":"15","author":"Shaw","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31083\/j.rcm2301039","article-title":"Identification and treatment of the vulnerable coronary plaque","volume":"23","author":"van Veelen","year":"2022","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0067","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/eurjpc\/zwab067","article-title":"Cardiovascular risk stratification by coronary computed tomography angiography imaging: current state-of-the-art","volume":"29","author":"Antonopoulos","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0068","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.3390\/ijms16023740","article-title":"Coronary CT angiography in managing atherosclerosis","volume":"16","author":"Eckert","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0069","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamacardio.2017.4973","article-title":"Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial","volume":"3","author":"Ferencik","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2022.100451_bib0070","author":"Cury","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0071","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcct.2017.05.001","article-title":"Prognostic value of segment involvement score compared to other measures of coronary atherosclerosis by computed tomography: a systematic review and meta-analysis","volume":"11","author":"Ayoub","year":"2017","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.ajpc.2022.100451_bib0072","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijcard.2016.12.137","article-title":"Long-term prognostic impact of CT-Leaman score in patients with non-obstructive CAD: Results from the COronary CT Angiography EvaluatioN For Clinical Outcomes InteRnational Multicenter (CONFIRM) study","volume":"231","author":"Andreini","year":"2017","journal-title":"Int J Cardiol"},{"issue":"18","key":"10.1016\/j.ajpc.2022.100451_bib0073","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-Attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish computed tomography of the HEART)","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0074","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0075","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00330-019-06470-8","article-title":"Computed tomography angiography-derived fractional flow reserve (CT-FFR) for the detection of myocardial ischemia with invasive fractional flow reserve as reference: systematic review and meta-analysis","volume":"30","author":"Zhuang","year":"2020","journal-title":"Eur Radiol"},{"issue":"18","key":"10.1016\/j.ajpc.2022.100451_bib0076","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jacc.2018.07.043","article-title":"Coronary CT angiographic and flow reserve-guided management of patients with stable ischemic heart disease","volume":"72","author":"N\u00f8rgaard","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ajpc.2022.100451_bib0077","first-page":"e368","article-title":"AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ajpc.2022.100451_bib0078","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jcct.2017.08.001","article-title":"Effect of the ratio of coronary arterial lumen volume to left ventricle myocardial mass derived from coronary CT angiography on fractional flow reserve","volume":"11","author":"Taylor","year":"2017","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0079","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jacc.2013.03.058","article-title":"Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy)","volume":"62","author":"Kini","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcct.2022.02.001","article-title":"Debates in cardiac CT: coronary CT angiography is the best test in asymptomatic patients","volume":"16","author":"Meah","year":"2022","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"10","key":"10.1016\/j.ajpc.2022.100451_bib0081","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Coronary CT angiography and 5-year risk of myocardial infarction","volume":"379","author":"Investigators","year":"2018","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ajpc.2022.100451_bib0082","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1415516","article-title":"Outcomes of anatomical versus functional testing for coronary artery disease","volume":"372","author":"Douglas","year":"2015","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ajpc.2022.100451_bib0083","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1001\/jama.2014.15825","article-title":"Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial","volume":"312","author":"Muhlestein","year":"2014","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.ajpc.2022.100451_bib0110","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ajpc.2022.100451_bib0143","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"issue":"9435","key":"10.1016\/j.ajpc.2022.100451_bib0144","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ajpc.2022.100451_bib0145","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.118.039415","article-title":"Ezetimibe lipid-lowering trial on prevention of atherosclerotic cardiovascular disease in 75 or Older (EWTOPIA 75)","author":"Ouchi","year":"2019","journal-title":"Circulation"},{"issue":"9784","key":"10.1016\/j.ajpc.2022.100451_bib0146","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ajpc.2022.100451_bib0097","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ajpc.2022.100451_bib0098","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0147","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The lipid research clinics coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2022.100451_bib0148","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ahj.2020.10.060","article-title":"Rationale and design of the CLEAR-outcomes trial: evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance","volume":"235","author":"Nicholls","year":"2021","journal-title":"Am Heart J"},{"issue":"16","key":"10.1016\/j.ajpc.2022.100451_bib0114","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0103","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0149","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1203859","article-title":"n\u20133 fatty acids and cardiovascular outcomes in patients with dysglycemia","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ajpc.2022.100451_bib0150","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes Mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0151","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjmed.2016.07.038","article-title":"Role of niacin in current clinical practice: a systematic review","volume":"130","author":"Garg","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.ajpc.2022.100451_bib0084","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5607349","article-title":"The correlation of dyslipidemia with the extent of coronary artery disease in the multiethnic study of atherosclerosis","author":"Abd alamir","year":"2018","journal-title":"J Lipids"},{"key":"10.1016\/j.ajpc.2022.100451_bib0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2019.02.019","article-title":"Remnant cholesterol and coronary atherosclerotic plaque burden assessed by computed tomography coronary angiography","volume":"284","author":"Lin","year":"2019","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0086","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.atherosclerosis.2006.10.006","article-title":"The differential associations between HDL, non-HDL and total cholesterols and atherosclerotic calcium deposits in multiple vascular beds","volume":"194","author":"Allison","year":"2007","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.ajpc.2022.100451_bib0087","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jacc.2007.03.009","article-title":"Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study","volume":"49","author":"Loria","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0088","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacl.2020.12.005","article-title":"The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction","volume":"15","author":"Orringer","year":"2021","journal-title":"J Clin Lipidol"},{"issue":"14","key":"10.1016\/j.ajpc.2022.100451_bib0089","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American college of cardiology solution set oversight committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ajpc.2022.100451_bib0090","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ajpc.2022.100451_bib0091","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11883-011-0199-7","article-title":"The Heinz Nixdorf Recall study and its potential impact on the adoption of atherosclerosis imaging in European primary prevention guidelines","volume":"13","author":"Mahabadi","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ajpc.2022.100451_bib0092","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2020.10.009","article-title":"Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: the coronary artery calcium consortium","volume":"316","author":"Osei","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2022.100451_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100371","article-title":"There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision. A review of current practice and recommendations for improved effectiveness","author":"Makover","year":"2022","journal-title":"Am J Prev Cardiol"},{"issue":"16","key":"10.1016\/j.ajpc.2022.100451_bib0094","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2010.09.082","article-title":"Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg\/dl with rosuvastatin","volume":"57","author":"Hsia","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"9976","key":"10.1016\/j.ajpc.2022.100451_bib0095","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.ajpc.2022.100451_bib0096","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/joim.12614","article-title":"Can LDL cholesterol be too low? Possible risks of extremely low levels","volume":"281","author":"Olsson","year":"2017","journal-title":"J Intern Med"},{"issue":"25","key":"10.1016\/j.ajpc.2022.100451_bib0099","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis","volume":"60","author":"Ference","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jcmg.2017.01.029","article-title":"Statin trials, cardiovascular events, and coronary artery calcification","volume":"11","author":"Mortensen","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.ajpc.2022.100451_bib0102","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jcmg.2020.03.017","article-title":"CAD severity on cardiac CTA identifies patients with most benefit of treating LDL-cholesterol to ACC\/AHA and ESC\/EAS targets","volume":"13","author":"Mortensen","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/clc.22856","article-title":"Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200\u2013499 mg\/dL) on statin therapy: rationale and design of the EVAPORATE study","volume":"41","author":"Budoff","year":"2018","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2022.100451_bib0105","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jcmg.2022.03.002","article-title":"Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction","volume":"15","author":"Nicholls","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ajpc.2022.100451_bib0106","doi-asserted-by":"crossref","DOI":"10.20945\/2359-3997000000306","article-title":"Choosing statins: a review to guide clinical practice","author":"Borges R de","year":"2020","journal-title":"Arch Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0107","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCOUTCOMES.111.000071","article-title":"Comparative tolerability and harms of individual statins","volume":"6","author":"Naci","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajpc.2022.100451_bib0108","first-page":"S1933","article-title":"NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient","author":"Cheeley","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0109","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamacardio.2018.4936","article-title":"Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease","volume":"4","author":"Rodriguez","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"9326","key":"10.1016\/j.ajpc.2022.100451_bib0111","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20\u2008536 high-risk individuals: a randomised placebocontrolled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2022.100451_bib0112","first-page":"415","article-title":"Ezetimibe therapy: mechanism of action and clinical update","volume":"8","author":"Phan","year":"2012","journal-title":"Vasc Health Risk Manag"},{"issue":"5","key":"10.1016\/j.ajpc.2022.100451_bib0113","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2796.2008.02062.x","article-title":"Ezetimibe monotherapy for cholesterol lowering in 2722 people: systematic review and meta-analysis of randomized controlled trials","volume":"265","author":"Pandor","year":"2009","journal-title":"J Intern Med"},{"issue":"7","key":"10.1016\/j.ajpc.2022.100451_bib0115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011662","article-title":"Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance","volume":"8","author":"Laufs","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.ajpc.2022.100451_bib0116","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014116","article-title":"Remnant cholesterol and the risk of coronary artery calcium progression: insights from the CARDIA and MESA study","volume":"15","author":"Hao","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0117","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12933-020-01008-5","article-title":"Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline","volume":"19","author":"Won","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0118","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.atherosclerosis.2013.08.019","article-title":"Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study","volume":"231","author":"Zeb","year":"2013","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.ajpc.2022.100451_bib0119","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2352-3018(14)00032-0","article-title":"Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial","volume":"2","author":"Lo","year":"2015","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9149(00)00820-1","article-title":"Rates of progression of coronary calcium by electron beam tomography","volume":"86","author":"Budoff","year":"2000","journal-title":"Am J Cardiol"},{"issue":"27","key":"10.1016\/j.ajpc.2022.100451_bib0121","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJM199812313392703","article-title":"Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography","volume":"339","author":"Callister","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajpc.2022.100451_bib0122","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/CIRCULATIONAHA.104.512681","article-title":"Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women","volume":"112","author":"Raggi","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajpc.2022.100451_bib0123","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2005.02.089","article-title":"Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis heart study randomized clinical trial","volume":"46","author":"Arad","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ajpc.2022.100451_bib0124","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.jacc.2019.02.060","article-title":"Prognostic implications of plaque characteristics and stenosis severity in patients with coronary artery disease","volume":"73","author":"Lee","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2022.100451_bib0125","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ajpc.2022.100451_bib0126","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jacc.2021.10.044","article-title":"Association of lipoprotein(a) with atherosclerotic plaque progression","volume":"79","author":"Kaiser","year":"2022","journal-title":"J Am Coll Cardiol"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667722001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667722001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:37:56Z","timestamp":1763005076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667722001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":151,"alternative-id":["S2666667722001350"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2022.100451","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging subclinical coronary atherosclerosis to guide lipid management, are we there yet?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2022.100451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100451"}}